{
  "report_rows": [
    {
      "kpi": "Diluted EPS",
      "prediction": "MISS",
      "answer": "pred ~$3.15 vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Management-fee revenue",
      "prediction": "MISS",
      "answer": "pred ~$847M vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Exchange combined ratio",
      "prediction": "MISS",
      "answer": "pred ~111% vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "DWP / management-fee growth (Q3 2026)",
      "prediction": "LOWER",
      "answer": "guide ~low-single-digit growth vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Profitability / product rollout (H2 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide: continued rollout, no numerical range vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -7.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -9.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 forward growth concern drives estimate pressure",
  "day5_confidence": "LOW"
}